About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of EVO756 in Adults With Migraine

NCT07616128·26 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Nichole Baio
CONTACT
(650) 319-4553 nichole.baio@evommune.com

Lead

Evommune, Inc.

Age

18–64

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adults aged 18 to \<65 years
Migraine with or without aura, per ICHD-3 criteria
History of failure with prior preventive migraine treatments
Not currently using migraine preventive therapy

You may not be if

Difficulty distinguishing migraine from other headache types or presence of other primary headache disorders
Use of certain medications
Any clinically significant medical, psychiatric, neurological, cardiovascular, or laboratory abnormalities

The record

StatusRecruiting

PhasePhase 2

Taking part330

StartedJul 2026

UpdatedSep 3, 2026

Conditions

Where26

Trialsphere Corp
Chandler, Arizona, United States
Buena Park Research Center
Buena Park, California, United States
Neuro Pain Research Center
Fresno, California, United States

Clareo Health | Study of EVO756 in Adults With Migraine